The World Health Organization listed KM Biologics' mpox vaccine for emergency use on Tuesday, making it the second shot to get the approval of the global health agency.
It declared mpox a global public health emergency for the second time in two years in August after a new variant of the virus, called clade Ib, spread from the Democratic Republic of Congo to neighboring countries.
In September, after facing criticism for moving too slowly on vaccines, the agency cleared Bavarian Nordic's vaccine for mpox and said it was considering LC16, made by Japan's KM Biologics, as a potential vaccine option.
